Stock A246960 SCL SCIENCE INC.
Add to a list
To use this feature you must be a member
Log inSign up

News SCL Science Inc.

Equities

A246960

KR7246960009

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-13 EDT 		5-day change 1st Jan Change
8,960 KRW +2.17% Intraday chart for SCL Science Inc. +2.63% +1.01%
02-07 H2U Corp. announced that it has received KRW 1.29506497 billion in funding from InnoTherapy, Inc. CI
2023 H2U Corp. announced that it has received KRW 1.2171 billion in funding from InnoTherapy, Inc. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
H2U Corp. announced that it has received KRW 1.29506497 billion in funding from InnoTherapy, Inc.
CI
H2U Corp. announced that it has received KRW 1.2171 billion in funding from InnoTherapy, Inc.
CI
InnoTherapy, Inc. announced that it has received KRW 5.9999961 billion in funding from Scl Holdings and another investor
CI
Health to U Corporation announced that it has received funding from InnoTherapy, Inc.
CI
H2U Corp. announced that it expects to receive KRW 1.2171 billion in funding from InnoTherapy, Inc.
CI
InnoTherapy, Inc. announced that it expects to receive KRW 5.9999961 billion in funding
CI
PhAST Corp. announced that it has received KRW 1.30609774 billion in funding from InnoTherapy, Inc.
CI
Lee Moon Su completed the acquisition of a 98.04% stake in NVC 2019 Bio Health Care Investment Association from InnoTherapy, Inc.
CI
Lee Moon Su agreed to acquire 98.039216% stake in NVC 2019 Bio Health Care Investment Association from InnoTherapy, Inc. for approximately KRW5 billion.
CI
PhAST Corp. announced that it expects to receive KRW 1.30609774 billion in funding from InnoTherapy, Inc.
CI
InnoTherapy, Inc. announced that it has received KRW 4.999995 billion in funding from SCL Healthcare Co., Ltd., Seoul Clinical Laboratories
CI
InnoTherapy, Inc. announced that it expects to receive KRW 4.999995 billion in funding from SCL Healthcare Co., Ltd., Seoul Clinical Laboratories
CI
SCL Healthcare Co., Ltd. completed the acquisition of 22.97% stake in InnoTherapy, Inc. from Lee, Moon Soo.
CI
SCL Healthcare Co., Ltd. agreed to acquire 22.97% stake in InnoTherapy, Inc. from Lee, Moon Soo for KRW 21.8 billion.
CI
InnoTherapy, Inc. announced that it has received KRW 14.999868397 billion in funding from a group of investors
CI
InnoTherapy, Inc. announced that it expects to receive KRW 7.5 billion in funding from Samsung Securities Co. Ltd., Investment Arm, KB Securities Co., Ltd., Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, His-Story Investment Co.,Ltd., Shinhan Bank, Investment Arm, Shinhan Bank, Investment Arm, and Pureun Mutual Savings Bank Co., Ltd and another investor
CI
InnoTherapy, Inc. cancelled the acquisition of 98.04% stake in NVC 2019 Bio Health Care Investment Association.
CI
InnoTherapy, Inc. agreed to acquire 98.04% stake in NVC 2019 Bio Health Care Investment Association for KRW 5 billion.
CI
NVC Partners announced that it has received KRW 1.1 billion in funding from InnoTherapy, Inc.
CI
InnoTherapy, Inc. has completed an IPO in the amount of KRW 9 billion.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A246960 Stock
  4. News SCL Science Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW